| |APRIL 20266C ONT E NT SPharma CDMOs in India & CDMO 2.0 Model: Detailed Review 2026Pharma Financial Year-End Checklist 2026: Key Stats & Compliance1034VANTAGE POINT14AFTER WORDNutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management?Arushi Jain, Director, Akums Drugs & Pharmaceuticals502842244638Pharmaceutical Procurement Strategies: How to Optimize CostsThe Future of Genomic Sequencing: Trends That Will Define the Next DecadeThe Future of Green Chemistry in API ProductionHow Pharma Authentication Tech Enhances ROI and SafetyAnti-Infectives: How New Research is Shaping Infection ControlRajat Jain, GM - Global Sourcing Engineering & Capex,Panacea BiotechRami Mehio, VP & Head - Software and Informatics Development, IlluminaAshok Kumar, President - Centre for Researchand Development,Ipca LaboratoriesAnkit Gupta, President, ASPADr. Pankaj Gupta, Senior Medical Director, Pfizer IndiaVIVID OUTLOOKANALYSISTransforming API & Pharma Manufacturing with Next-Gen EHS TechnologiesDr Kuber Jagdale,President - API Business Unit, Emcure Pharmaceuticals
< Page 5 | Page 7 >